Core Viewpoint - The announcement details the completion of a share transfer agreement involving 16,865,359 shares of Sanrenxing Media Group Co., Ltd., representing 8% of the company's total share capital, from the controlling shareholder to a new party, without affecting the company's control structure or governance [1][2][4]. Group 1: Share Transfer Agreement - On November 30, 2025, the controlling shareholder, Qingdao Duoduo Investment Co., Ltd., and associated parties signed a share transfer agreement to transfer 16,865,359 unrestricted circulating shares to Yan Jianya [1][3]. - The share transfer was confirmed by the Shanghai Stock Exchange and completed on February 2, 2026, with the shares representing 8% of the total share capital [2][4]. Group 2: Impact of the Transfer - The share transfer will not result in any changes to the controlling shareholder or actual controller of the company, nor will it involve a tender offer or significantly impact the company's governance structure or future operations [2][4]. - The transferred shares are free from any pledges or restrictions, complying with relevant laws and regulations [4].

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ■ 一、回购股份的基本情况 苏州华之杰电讯股份有限公司（以下简称"公司"）于2026年1月13日召开第三届董事会第十九次会议， 以5票同意、0票反对、0票弃权审议通过了《关于以集中竞价交易方式回购公司股份的议案》，同意公 司使用不低于人民币3,000万元（含），不超过人民5,000万元（含）自有资金及自筹资金回购公司股 份，用于员工持股计划或股权激励。回购股份价格为不超过人民币79.79元/股（含），回购股份方式为 集中竞价交易方式，回购股份期限为自公司董事会审议通过本次回购股份方案之日起12个月内。 具体内容详见公司于2026年1月14日在上海证券交易所网站（www.sse.com.cn）披露的《华之杰关于以 集中竞价交易方式回购公司股份的公告》（公告编号：2026-005）。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603400 证券简称：华之杰 公告编号：2026-016 苏州华之杰电讯股份有限公司 关于以集中竞价交易方式回购公司股份的进 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002471 证券简称：中超控股 公告编号：2026-006 江苏中超控股股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 三、是否存在应披露而未披露信息的说明 江苏中超控股股份有限公司（以下简称"公司"或"本公司"）于2026年2月2日、2月3日连续2个交易日收 盘价格涨幅偏离值累计达到21.20%，根据深圳证券交易所的有关规定，属于股票异常波动的情况。 二、公司关注、核实情况说明 针对公司股价异常波动，公司就相关事项进行了必要核实，现将有关核实情况说明如下： 1、经核查，公司前期披露的信息不存在需要更正、补充之处； 2、经核查，公司未发现近期公共媒体报道了可能或已经对本公司股票交易价格产生较大影响的未公开 重大信息； 3、经核查，近期公司经营情况及内外部经营环境未发生重大变化； 4、经核查，公司、控股股东和实际控制人不存在应披露而未披露的重大事项，或处于筹划阶段的重大 事项； 5、经核查，控股股东、实际控制人在公司本次股票交易异常波动期间未买卖本公司股票。 一、股 ...

自2026年2月5日（含）起，投资人通过利得基金（www.leadfund.com.cn）申购、定投、转换本公司旗 下基金，申购、定投、转换费率实行最低1折优惠。若原申购、定投、转换费率为固定费用的，则按固 定费用执行，不享有费率折扣。（具体折扣比例以利得基金页面公示为准） 具体实施费率优惠的结束时间及优惠措施以利得基金安排为准。 三、投资者可通过以下途径咨询有关详情 风险提示： 本公司承诺以诚实信用、勤勉尽责为原则，管理和运用基金资产，但不保证基金一定盈利，也不保证最 低收益。基金的过往业绩及其净值高低并不预示其未来业绩表现。本公司提醒投资者，投资基金前应认 真阅读基金的《基金合同》《招募说明书》等法律文件，了解基金的风险收益特征，并根据自身的投资 目的、投资期限、投资经验、资产状况等判断基金是否与投资者的风险承受能力相适应。敬请投资者注 意投资风险。 根据凯石基金管理有限公司（以下简称"本公司"）与上海利得基金销售有限公司（以下简称"利得基 金"）签署的销售服务协议，自2026年2月5日起，投资者可通过利得基金办理本公司旗下部分基金的账 户申购、定投、赎回、转换等业务。 一、适用基金 ■ 二、费率优惠活动 ...

Group 1 - The company held its 14th meeting of the third board of directors on February 3, 2026, with all 7 directors present, including 3 via telecommunication [2][4] - The board approved the proposal to use bank acceptance bills to pay for the required funds for investment projects and to replace them with raised funds [3][12] - The proposal was reviewed and approved by the board's audit committee prior to the board meeting [3][11] Group 2 - The company raised a total of RMB 485.10 million from its initial public offering, with a net amount of RMB 397.05 million after deducting issuance costs [7] - The company plans to adjust the investment amounts for its projects due to the actual raised funds being lower than initially disclosed [8] - The use of bank acceptance bills is intended to improve the efficiency of fund usage and reduce financial costs without affecting the implementation of investment projects [11][14] Group 3 - The operational details for using bank acceptance bills include strict adherence to the company's fund management system and internal approval processes [9][10] - The financial department will maintain a detailed ledger of transactions related to the use of bank acceptance bills and ensure compliance with regulatory requirements [10] - The proposal does not require shareholder approval and has been deemed beneficial for the company and its shareholders [13][15]

Core Viewpoint - The company, Shanghai Metters Bonway Apparel Co., Ltd., is progressing with its investment in a joint venture, Guizhou Meibang New Energy Textile and Apparel Technology Co., Ltd., with specific performance commitments outlined for its subsidiary, Shanghai Bangyun Industrial Co., Ltd. [2][3] Group 1: Investment Overview - The company approved the establishment of a joint venture with Guizhou Textile Industry Development Group Co., Ltd. and Guizhou Agricultural Modernization Development Equity Investment Fund Partnership, with a registered capital of RMB 100 million [3]. - The capital contributions are as follows: Guizhou Textile Group will contribute RMB 51 million (51%), Guizhou Agricultural Fund will contribute RMB 39 million (39%), and Shanghai Bangyun will contribute RMB 10 million (10%) [3]. Group 2: Management and Performance Commitments - Mr. Zhou Chengjian has been appointed as the general manager of the joint venture, with Shanghai Bangyun acting as the performance commitment party, responsible for achieving the agreed performance targets [4][5]. - If the joint venture fails to meet the performance targets during the assessment period, Shanghai Bangyun must compensate the shortfall in net profit within 30 days after the audit [4][5]. Group 3: Joint Venture Registration - The joint venture, Guizhou Meibang New Energy Textile and Apparel Technology Co., Ltd., has completed its business registration and obtained a business license [5][6]. - The company is registered with a capital of RMB 100 million and is located in Dafa County, Bijie City, Guizhou Province, with a variety of business activities including textile processing and apparel manufacturing [6].

Core Viewpoint - Shenzhen Oat Technology Co., Ltd. experienced a significant stock price fluctuation, with a cumulative closing price deviation of 30% over three consecutive trading days, indicating abnormal trading activity [2][4]. Group 1: Stock Trading Abnormalities - The company's stock price increased by a cumulative 30% on January 30, February 2, and February 3, 2026, which qualifies as abnormal trading according to the Shanghai Stock Exchange rules [2][4]. - The company has confirmed that its daily operations are normal and there have been no significant changes [5]. Group 2: Company Operations and Major Events - The company conducted a self-examination and found that its production and operational activities are normal, with no major changes in the market environment or industry policies [5]. - There are no undisclosed major events, such as mergers, debt restructuring, or asset injections, as confirmed by the company and its major shareholders [6][9]. Group 3: Market Trends and Product Development - Recent market interest has surged in concepts like "CPO," "optical communication," and "silicon photonic wafer testing," leading to active market performance in related sectors [7]. - The company’s acquisition of AXIS-TEC PTE.LTD. includes products related to silicon photonic wafer testing, but these products are still in the early stages of market promotion, contributing less than 1% to the company's sales revenue [8].

Core Viewpoint - The company, Aorui De Optoelectronics Co., Ltd., is progressing with its share repurchase and reduction plan, aimed at maintaining company value and shareholder rights [2][3]. Group 1: Share Repurchase Details - The company repurchased shares from June 21, 2024, to September 20, 2024, through centralized bidding, with plans to sell these shares within 36 months after the announcement of the repurchase results [2]. - If the company fails to sell the repurchased shares within the specified period, all unsold shares will be canceled [2]. Group 2: Reduction Plan Progress - On September 27, 2025, the company announced a plan to reduce the repurchased shares through centralized bidding, with a reduction period starting 15 trading days after the announcement and lasting for 6 months [3]. - The company disclosed the progress of the reduction plan on November 15, December 2, 2025, and January 6, 2026, in accordance with the Shanghai Stock Exchange regulations [3]. Group 3: Reduction Implementation Status - As of January 31, 2026, the company had reduced 8,408,000 shares, representing 0.31% of the total shares, with a total transaction amount of 31,755,473 yuan, at an average price of 3.78 yuan per share [4]. - The total number of repurchased shares held in the dedicated account was 27,313,000, accounting for 0.99% of the total shares [4]. Group 4: Compliance and Regulations - The company confirmed that the reduction plan is consistent with previously disclosed plans and commitments [6]. - There were no significant events such as high dividends or mergers that could affect the reduction plan during the reduction period [7].

Core Viewpoint - Zhejiang Huahai Pharmaceutical Co., Ltd. has received approval from the National Medical Products Administration for a supplemental application to produce a new specification (0.1g) of the injectable drug Cytarabine, expanding its product line and enhancing market competitiveness [1][4]. Group 1: Drug Information - The drug approved is Cytarabine for injection, with a new specification of 0.1g, which is a chemical drug registered under the approval number H20269025 [1]. - Cytarabine is used for the induction and maintenance treatment of acute non-lymphocytic leukemia in adults and children, and it is effective against other types of leukemia as well [2]. - The company had previously obtained a registration certificate for the 0.5g specification of Cytarabine in March 2025, with a projected domestic market sales amount of approximately RMB 306 million for 2025 [2]. Group 2: R&D Investment - The company has invested approximately RMB 8.17 million in the research and development of the Cytarabine project to date [3]. Group 3: Impact on the Company - The approval of the 0.1g specification is considered equivalent to passing a consistency evaluation, which will enrich the company's product line and improve its market competitiveness [4].

证券代码：600452 证券简称：涪陵电力 编号：2026一005 重庆涪陵电力实业股份有限公司 关于第九届四次董事会决议的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，对公告的虚假记载、误导性陈述或者重大 遗漏负连带责任。 重庆涪陵电力实业股份有限公司（以下简称"公司"）于2026年2月3日以通讯方式召开了第九届四次董事 会会议，本次董事会会议发出董事表决票9份，实际收回董事表决票9份。会议的召集、召开符合《公司 法》《重庆涪陵电力实业股份有限公司章程》《重庆涪陵电力实业股份有限公司董事会议事规则》有关 规定。 本次董事会会议审议并通过了《关于聘任公司高级管理人员的议案》。 公司原副总经理常涛先生因工作变动，已离任。按照《公司法》《重庆涪陵电力实业股份有限公司章 程》《重庆涪陵电力实业股份有限公司董事会提名委员会议事规则》的有关规定，经公司总经理提名、 董事会提名委员会审议通过，同意聘任刘会灯先生担任公司副总经理，任期至第九届董事会届满为止。 （个人简历附后） 曾任国网重庆市区供电公司办公室行政秘书，运检部变电运检室二次班班组工程师，渝中营配协同工作 组主任助理、副主任；国网重庆市电力公司市区 ...